AMGN Amgen, Inc.
Amgen, Inc. (AMGN) is expected to report earnings on November 3, 2026, after the market close. The consensus earnings estimate is $5.71 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +5.6% since its last earnings release on August 4, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Amgen, Inc.
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
Sector
Healthcare
Industry
Biotechnology
Held By 10 ETFs, by dollar flow
- QQQ Invesco QQQ Trust
- OEF iShares S&P 100 ETF
- QTOP iShares Nasdaq Top 30 Stocks ETF
- DIA SPDR Dow Jones Industrial Average ETF
- HDV iShares Core High Dividend ETF
- XLV Health Care Select Sector SPDR Fund
- IYH iShares U.S. Healthcare ETF
- IXJ iShares Global Healthcare ETF
- BMED iShares Health Innovation Active ETF
- BBH VanEck Biotech ETF